The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 17, 2012, Pages

  Rajurkar, Mihir ^a   De Jesus Monge, Wilfredo E ^a   Driscoll, David R ^a   Appleman, Victoria A ^a   Huang, He ^a   Cotton, Jennifer L ^a   Klimstra, David S ^b   Zhu, Lihua J ^a   Simin, Karl ^a   Xu, Lan ^a   McMahon, Andrew P ^c,d   Lewis, Brian C ^a   Mao, Junhao ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; K RAS PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR GLI3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; IN VIVO CULTURE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS DUCT ADENOCARCINOMA; PRIORITY JOURNAL; REGULATORY MECHANISM; TUMOR GROWTH;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL PROLIFERATION; GENES, RAS; I-KAPPA B PROTEINS; MICE; NF-KAPPA B; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 84860169406     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1114168109     Document Type: Article

References (70)

1. Bardeesy N, DePinho RA (2002) Pancreatic cancer biology and genetics. Nat Rev Cancer 2:897-909. (Pubitemid 37328891)
2. Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer. Lancet 363:1049-1057. (Pubitemid 38410779)
3. Jones S, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-1806.
4. Almoguera C, et al. (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549-554.
5. Hingorani SR, et al. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4:437-450. (Pubitemid 38050041)
6. Aguirre AJ, et al. (2003) Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 17:3112-3126. (Pubitemid 38040774)
7. Hingorani SR, et al. (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7:469-483. (Pubitemid 40719130)
8. McMahon AP, Ingham PW, Tabin CJ (2003) Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 53:1-114. (Pubitemid 137639458)
9. Lum L, Beachy PA (2004) The Hedgehog response network: Sensors, switches, and routers. Science 304:1755-1759. (Pubitemid 38787882)
10. Hooper JE, Scott MP (2005) Communicating with Hedgehogs. Nat Rev Mol Cell Biol 6:306-317. (Pubitemid 40516897)
11. Morris JP IV, Wang SC, Hebrok M (2010) KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 10:683-695.
12. Berman DM, et al. (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425:846-851. (Pubitemid 37351469)
13. Thayer SP, et al. (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425:851-856. (Pubitemid 37355945)
14. Pasca di Magliano M, et al. (2006) Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 20:3161-3173.
15. Morton JP, et al. (2007) Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci USA 104:5103-5108. (Pubitemid 47186183)
16. Yauch RL, et al. (2008) A paracrine requirement for hedgehog signalling in cancer. Nature 455:406-410.
17. Olive KP, et al. (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324:1457-1461.
18. Nolan-Stevaux O, et al. (2009) GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 23:24-36.
19. Teglund S, Toftgård R (2010) Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta 1805:181-208.
20. Rubin LL, de Sauvage FJ (2006) Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov 5:1026-1033. (Pubitemid 44835129)
21. Barakat MT, Humke EW, Scott MP (2010) Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer. Trends Mol Med 16:337-348.
22. Bailey JM, et al. (2008) Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res 14:5995-6004.
23. Tian H, et al. (2009) Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci USA 106:4254-4259.
24. Dennler S, et al. (2007) Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res 67:6981-6986. (Pubitemid 47105546)
25. Vokes SA, Ji H, Wong WH, McMahon AP (2008) A genome-scale analysis of the cis-regulatory circuitry underlying sonic hedgehog-mediated patterning of the mammalian limb. Genes Dev 22:2651-2663.
26. Kawaguchi Y, et al. (2002) The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 32:128-134. (Pubitemid 34977207)
27. Tuveson DA, et al. (2004) Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5:375-387. (Pubitemid 38482073)
28. Jonkers J, et al. (2001) Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29:418-425. (Pubitemid 34326692)
29. Stecca B, Ruiz i Altaba A (2009) A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J 28:663-676.
30. Vokes SA, et al. (2007) Genomic characterization of Gli-activator targets in sonic hedgehog-mediated neural patterning. Development 134:1977-1989. (Pubitemid 46939242)
31. Lee EY, et al. (2010) Hedgehog pathway-regulated gene networks in cerebellum development and tumorigenesis. Proc Natl Acad Sci USA 107:9736-9741.
32. Morton JP, et al. (2010) Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA 107:246-251.
33. Downward J (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3:11-22.
34. Yang SH, et al. (2008) Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/beta3-catenin signaling. Nat Genet 40:1130-1135.
35. Ulloa F, Itasaki N, Briscoe J (2007) Inhibitory Gli3 activity negatively regulates Wnt/beta-catenin signaling. Curr Biol 17:545-550. (Pubitemid 46401379)
36. Alvarez-Medina R, Le Dreau G, Ros M, Martí E (2009) Hedgehog activation is required upstream of Wnt signalling to control neural progenitor proliferation. Development 136:3301-3309.
37. Shin K, et al. (2011) Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472:110-114.
38. Pasca di Magliano M, et al. (2007) Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS ONE 2:e1155.
39. Murtaugh LC, Law AC, Dor Y, Melton DA (2005) Beta-catenin is essential for pancreatic acinar but not islet development. Development 132:4663-4674. (Pubitemid 41685277)
40. Heiser PW, Lau J, Taketo MM, Herrera PL, Hebrok M (2006) Stabilization of beta-catenin impacts pancreas growth. Development 133:2023-2032. (Pubitemid 43881267)
41. Peters RT, Liao SM, Maniatis T (2000) IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol Cell 5:513-522.
42. Shen RR, Hahn WC (2011) Emerging roles for the non-canonical IKKs in cancer. Oncogene 30:631-641.
43. Boehm JS, et al. (2007) Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129:1065-1079. (Pubitemid 46891036)
44. Cheng A, et al. (2011) IκB Kinase ε expression in pancreatic ductal adenocarcinoma. Am J Clin Pathol 136:60-66.
45. Lauth M, Bergström A, Shimokawa T, Toftgård R (2007) Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 104:8455-8460. (Pubitemid 47175509)
46. Stecca B, et al. (2007) Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci USA 104:5895-5900. (Pubitemid 47175630)
47. Ho L, et al. (2009) Gli2 and p53 cooperate to regulate IGFBP-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors. Cancer Cell 16:126-136.
48. Flora A, Klisch TJ, Schuster G, Zoghbi HY (2009) Deletion of Atoh1 disrupts Sonic Hedgehog signaling in the developing cerebellum and prevents medulloblastoma. Science 326:1424-1427.
49. Ji Z, Mei FC, Xie J, Cheng X (2007) Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. J Biol Chem 282:14048-14055. (Pubitemid 47100411)
50. Hyman JM, et al. (2009) Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proc Natl Acad Sci USA 106:14132-14137.
51. Lauth M, et al. (2010) DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. Nat Struct Mol Biol 17:718-725.
52. Cervantes S, Lau J, Cano DA, Borromeo-Austin C, Hebrok M (2010) Primary cilia regulate Gli/Hedgehog activation in pancreas. Proc Natl Acad Sci USA 107:10109-10114.
53. Goetz SC, Ocbina PJ, Anderson KV (2009) The primary cilium as a Hedgehog signal transduction machine. Methods Cell Biol 94:199-222.
54. Seeley ES, Carrière C, Goetze T, Longnecker DS, Korc M (2009) Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia. Cancer Res 69:422-430.
55. Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H (1999) Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: Implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development 126:3915-3924. (Pubitemid 29440488)
56. Gu G, Dubauskaite J, Melton DA (2002) Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129:2447-2457. (Pubitemid 34863851)
57. Eichberger T, et al. (2006) Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. Genomics 87:616-632.
58. Kenney AM, Rowitch DH (2000) Sonic hedgehog promotes G(1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol Cell Biol 20:9055-9067. (Pubitemid 32245934)
59. Mill P, et al. (2005) Shh controls epithelial proliferation via independent pathways that converge on N-Myc. Dev Cell 9:293-303. (Pubitemid 41051747)
60. Mao J, et al. (2006) A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res 66:10171-10178. (Pubitemid 44672072)
61. Stecca B, Ruiz I Altaba A (2010) Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol Cell Biol 2:84-95.
62. Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18:2195-2224.
63. Greten FR, et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285-296. (Pubitemid 39061110)
64. Pikarsky E, et al. (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431:461-466. (Pubitemid 39329586)
65. Beroukhim R, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899-905.
66. Barbie DA, et al. (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108-112.
67. Meylan E, et al. (2009) Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 462:104-107.
68. Holcomb B, Yip-Schneider M, Schmidt CM (2008) The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy. Pancreas 36:225-235. (Pubitemid 351440925)
69. Lu Z, et al. (2011) miR-301a as an NF-κB activator in pancreatic cancer cells. EMBO J 30:57-67.
70. Nakashima H, et al. (2006) Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res 66:7041-7049. (Pubitemid 44197680)